Tonix Pharmaceuticals Holding Corp (TNXP) Stock Price

13.74 ▼ -0.16 (-1.15%)
Open: 13.965 Vol: 0 Day's range: 13.70 - 14.10 Apr 06, 13:20 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
TNXP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 13.78▲ 13.85▼ 13.90▼ 13.43▲ 13.76▲
MA10 13.80▼ 13.92▼ 13.88▼ 14.02▼ 14.17▼
MA20 13.88▼ 13.87▼ 13.87▼ 14.12▼ 15.73▼
MA50 13.93▼ 13.66▲ 13.52▲ 15.06▼ 24.47▼
MA100 13.85▼ 13.69▲ 14.37▼ 15.97▼ 47.15▼
MA200 13.89▼ 14.32▼ 14.15▼ 24.14▼ 4,645.36▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.010▼ -0.031▼ 0.000▼ -0.023▼ 0.589▲
RSI 41.148▼ 48.788▼ 51.265▲ 47.018▼ 39.240▼
STOCH 30.763     42.731     68.780     30.788     19.257▼
WILL %R -71.186     -73.256     -30.583     -59.568     -73.857    
CCI -45.447     -97.171     -0.431     -37.163     -68.088    
Latest Filters Detected On TNXP
MA $TNXP Price Crossed Above MA(7) Set Alert
▼ GAP $TNXP Open Gap Down %3 Set Alert
▼ GAP $TNXP Open Gap Down %2 Set Alert
CDL $TNXP Engulfing Candlestick Pattern Detected Set Alert
CDL $TNXP Marubozu Candlestick Pattern Detected Set Alert
Tonix Pharmaceuticals Holding Corp News
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World ...
Tuesday, March 31, 2026 04:38 AM
Borrelia burgdorferi OspA human monoclonal antibody in development as a single-dose Lyme prophylactic Phase 1 study of TNX-4800 demonstrated safety, tolerability, and pharmacokinetics supportive of ...
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World ...
Tuesday, March 31, 2026 04:22 AM
TNX-4800 is a long-acting anti-Borrelia burgdorferi OspA human monoclonal antibody in development as a single-dose Lyme prophylactic Phase 1 ...
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Monday, March 23, 2026 02:41 PM
Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease ...
TNXP historical stock data
date open high low close volume
06/04/26 13.965 14.10 13.70 13.785 135,669
02/04/26 13.16 14.00 13.08 13.90 311,329
01/04/26 13.80 14.8999 13.63 13.68 452,113
31/03/26 12.19 13.85 12.16 13.75 498,211
30/03/26 12.70 12.70 11.6028 12.03 742,629
27/03/26 13.57 13.64 12.70 12.88 766,035
26/03/26 14.30 14.9799 13.75 13.75 403,163
25/03/26 15.50 15.915 14.97 15.00 333,915
24/03/26 15.84 16.35 15.20 15.34 418,146
23/03/26 15.10 16.1898 15.10 16.08 557,653
Quote Details
52wk Low:11.603
52wk High:69.97
Vol:0
Avg Vol(3m):5.5M
1Y Chng:-7.85%
1M Chng:-2.85%
Add to Watch List
More Information
Index US Composite
Market Cap. 197.46M